| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Amyotrophic Lateral Sclerosis | 29 | 2024 | 505 | 6.430 |
Why?
|
| RNA-Binding Protein FUS | 14 | 2023 | 53 | 5.430 |
Why?
|
| Induced Pluripotent Stem Cells | 3 | 2024 | 150 | 1.610 |
Why?
|
| Mutation | 19 | 2024 | 2615 | 1.570 |
Why?
|
| Nuclear Pore Complex Proteins | 2 | 2023 | 29 | 1.470 |
Why?
|
| Neurodegenerative Diseases | 4 | 2024 | 145 | 1.450 |
Why?
|
| Profilins | 4 | 2024 | 45 | 1.450 |
Why?
|
| Superoxide Dismutase | 7 | 2022 | 225 | 1.400 |
Why?
|
| Frontotemporal Dementia | 6 | 2023 | 150 | 1.370 |
Why?
|
| Motor Neurons | 7 | 2022 | 212 | 1.310 |
Why?
|
| Stress, Physiological | 3 | 2019 | 193 | 1.260 |
Why?
|
| Brain Injuries, Traumatic | 4 | 2023 | 98 | 1.190 |
Why?
|
| Cytoplasmic Granules | 4 | 2019 | 53 | 1.080 |
Why?
|
| Active Transport, Cell Nucleus | 3 | 2023 | 114 | 1.020 |
Why?
|
| Neurons | 10 | 2023 | 923 | 0.960 |
Why?
|
| Superoxide Dismutase-1 | 9 | 2022 | 143 | 0.920 |
Why?
|
| Microglia | 3 | 2024 | 242 | 0.870 |
Why?
|
| Skull | 1 | 2023 | 49 | 0.790 |
Why?
|
| Single-Domain Antibodies | 1 | 2022 | 18 | 0.780 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2023 | 86 | 0.770 |
Why?
|
| Protein Folding | 9 | 2022 | 268 | 0.760 |
Why?
|
| Polymerization | 1 | 2021 | 36 | 0.700 |
Why?
|
| Axonal Transport | 3 | 2017 | 32 | 0.700 |
Why?
|
| Actins | 2 | 2021 | 260 | 0.650 |
Why?
|
| Membrane Glycoproteins | 1 | 2023 | 669 | 0.620 |
Why?
|
| Golgi Apparatus | 1 | 2019 | 64 | 0.600 |
Why?
|
| Receptors, AMPA | 1 | 2019 | 42 | 0.600 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2017 | 149 | 0.600 |
Why?
|
| Animals | 26 | 2023 | 20716 | 0.600 |
Why?
|
| Glutamic Acid | 1 | 2019 | 99 | 0.590 |
Why?
|
| Cell Nucleus | 4 | 2019 | 628 | 0.580 |
Why?
|
| Endoplasmic Reticulum | 1 | 2019 | 174 | 0.560 |
Why?
|
| Mice | 19 | 2023 | 10864 | 0.540 |
Why?
|
| Humans | 44 | 2024 | 63535 | 0.540 |
Why?
|
| Proteostasis Deficiencies | 2 | 2021 | 6 | 0.520 |
Why?
|
| Cyclophilin A | 2 | 2010 | 34 | 0.510 |
Why?
|
| Protein Biosynthesis | 1 | 2019 | 320 | 0.510 |
Why?
|
| Oxidative Stress | 4 | 2013 | 297 | 0.490 |
Why?
|
| Calcium | 2 | 2019 | 576 | 0.480 |
Why?
|
| Cells | 1 | 2014 | 32 | 0.440 |
Why?
|
| Cytoplasm | 5 | 2023 | 277 | 0.430 |
Why?
|
| Hypertonic Solutions | 1 | 2013 | 4 | 0.420 |
Why?
|
| RNA, Messenger | 2 | 2019 | 1535 | 0.420 |
Why?
|
| Epitopes | 1 | 2014 | 290 | 0.400 |
Why?
|
| DNA Repair | 1 | 2014 | 248 | 0.380 |
Why?
|
| Cell Line | 6 | 2018 | 2041 | 0.370 |
Why?
|
| Mutant Proteins | 4 | 2021 | 105 | 0.360 |
Why?
|
| HIV-1 | 2 | 2010 | 723 | 0.350 |
Why?
|
| Autoantibodies | 1 | 2011 | 183 | 0.340 |
Why?
|
| Cell Proliferation | 1 | 2014 | 988 | 0.330 |
Why?
|
| Brain | 7 | 2023 | 1556 | 0.330 |
Why?
|
| Capsid Proteins | 1 | 2010 | 101 | 0.310 |
Why?
|
| Spinal Cord | 5 | 2018 | 205 | 0.300 |
Why?
|
| Protein Conformation | 5 | 2015 | 780 | 0.280 |
Why?
|
| Drug Delivery Systems | 1 | 2010 | 325 | 0.260 |
Why?
|
| C9orf72 Protein | 3 | 2023 | 114 | 0.260 |
Why?
|
| alpha-Synuclein | 2 | 2006 | 35 | 0.260 |
Why?
|
| Oxidation-Reduction | 5 | 2018 | 326 | 0.250 |
Why?
|
| HeLa Cells | 2 | 2021 | 536 | 0.250 |
Why?
|
| Lewy Body Disease | 1 | 2006 | 14 | 0.250 |
Why?
|
| RNA Processing, Post-Transcriptional | 2 | 2019 | 103 | 0.240 |
Why?
|
| Cholesterol | 2 | 2006 | 259 | 0.240 |
Why?
|
| Proteomics | 2 | 2019 | 283 | 0.230 |
Why?
|
| Crystallography, X-Ray | 3 | 2015 | 432 | 0.220 |
Why?
|
| Pick Disease of the Brain | 1 | 2023 | 6 | 0.210 |
Why?
|
| Disease Models, Animal | 4 | 2021 | 2196 | 0.210 |
Why?
|
| Models, Molecular | 6 | 2012 | 1151 | 0.210 |
Why?
|
| Proteins | 3 | 2015 | 753 | 0.200 |
Why?
|
| Intravital Microscopy | 1 | 2023 | 12 | 0.200 |
Why?
|
| Brain Concussion | 1 | 2023 | 34 | 0.200 |
Why?
|
| Cysteine | 2 | 2014 | 108 | 0.200 |
Why?
|
| Neuronal Outgrowth | 1 | 2022 | 10 | 0.200 |
Why?
|
| Coloring Agents | 1 | 2023 | 54 | 0.200 |
Why?
|
| Cytophagocytosis | 1 | 2022 | 2 | 0.190 |
Why?
|
| Mass Spectrometry | 3 | 2014 | 301 | 0.190 |
Why?
|
| Head | 1 | 2023 | 54 | 0.190 |
Why?
|
| Synaptosomes | 1 | 2022 | 16 | 0.190 |
Why?
|
| Autophagy | 2 | 2015 | 226 | 0.190 |
Why?
|
| Recombinant Proteins | 3 | 2014 | 705 | 0.180 |
Why?
|
| Chronic Traumatic Encephalopathy | 1 | 2021 | 5 | 0.180 |
Why?
|
| Protein Conformation, alpha-Helical | 1 | 2021 | 22 | 0.180 |
Why?
|
| Tauopathies | 1 | 2021 | 19 | 0.170 |
Why?
|
| Capsid | 1 | 2002 | 95 | 0.170 |
Why?
|
| Phagocytosis | 1 | 2022 | 265 | 0.170 |
Why?
|
| DNA Repeat Expansion | 2 | 2023 | 58 | 0.170 |
Why?
|
| Superoxides | 1 | 2020 | 71 | 0.170 |
Why?
|
| Animals, Genetically Modified | 1 | 2021 | 299 | 0.160 |
Why?
|
| Cell Differentiation | 2 | 2022 | 1357 | 0.160 |
Why?
|
| Decapodiformes | 2 | 2017 | 14 | 0.160 |
Why?
|
| Coat Protein Complex I | 1 | 2019 | 5 | 0.160 |
Why?
|
| Arsenites | 1 | 2019 | 7 | 0.160 |
Why?
|
| Weight Loss | 1 | 2021 | 274 | 0.150 |
Why?
|
| Phenotype | 2 | 2021 | 1208 | 0.150 |
Why?
|
| Cell Line, Tumor | 3 | 2019 | 1470 | 0.150 |
Why?
|
| Nonsense Mediated mRNA Decay | 1 | 2018 | 27 | 0.150 |
Why?
|
| Mutation, Missense | 2 | 2010 | 185 | 0.150 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 2 | 2010 | 113 | 0.140 |
Why?
|
| Nipples | 1 | 2018 | 14 | 0.140 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2018 | 44 | 0.140 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2020 | 337 | 0.140 |
Why?
|
| Drosophila | 1 | 2021 | 435 | 0.140 |
Why?
|
| Protein Structure, Tertiary | 2 | 2014 | 674 | 0.140 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2012 | 719 | 0.140 |
Why?
|
| Male | 11 | 2023 | 29938 | 0.130 |
Why?
|
| Preoperative Care | 1 | 2018 | 194 | 0.130 |
Why?
|
| Protein Binding | 3 | 2014 | 1603 | 0.130 |
Why?
|
| Isoenzymes | 2 | 2014 | 139 | 0.120 |
Why?
|
| Kinetics | 3 | 2010 | 763 | 0.120 |
Why?
|
| Astrocytes | 3 | 2022 | 119 | 0.120 |
Why?
|
| Phenylbutyrates | 1 | 2015 | 6 | 0.120 |
Why?
|
| Haloperidol | 1 | 2015 | 16 | 0.120 |
Why?
|
| Dipeptides | 1 | 2015 | 68 | 0.120 |
Why?
|
| MAP Kinase Signaling System | 1 | 2017 | 226 | 0.120 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2014 | 248 | 0.120 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2015 | 54 | 0.120 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2015 | 36 | 0.110 |
Why?
|
| Phosphorylation | 2 | 2014 | 937 | 0.110 |
Why?
|
| M Phase Cell Cycle Checkpoints | 1 | 2014 | 4 | 0.110 |
Why?
|
| Hybridomas | 1 | 2014 | 63 | 0.110 |
Why?
|
| Primary Cell Culture | 1 | 2014 | 78 | 0.110 |
Why?
|
| Genetic Association Studies | 2 | 2014 | 120 | 0.110 |
Why?
|
| Gene Expression | 2 | 2014 | 843 | 0.110 |
Why?
|
| Escherichia coli | 2 | 2014 | 707 | 0.110 |
Why?
|
| Adult | 6 | 2018 | 16896 | 0.110 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 202 | 0.110 |
Why?
|
| In Vitro Techniques | 2 | 2015 | 490 | 0.110 |
Why?
|
| Sorbitol | 1 | 2013 | 2 | 0.110 |
Why?
|
| Protein Structure, Secondary | 1 | 2014 | 260 | 0.100 |
Why?
|
| Methylation | 1 | 2013 | 129 | 0.100 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2011 | 363 | 0.100 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 234 | 0.100 |
Why?
|
| Middle Aged | 5 | 2018 | 17659 | 0.100 |
Why?
|
| Female | 9 | 2023 | 32947 | 0.100 |
Why?
|
| Nerve Degeneration | 1 | 2013 | 72 | 0.100 |
Why?
|
| Blotting, Western | 1 | 2013 | 612 | 0.090 |
Why?
|
| Cell Death | 1 | 2013 | 285 | 0.090 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2013 | 178 | 0.090 |
Why?
|
| Survival | 1 | 2011 | 11 | 0.090 |
Why?
|
| Mice, Transgenic | 3 | 2023 | 1284 | 0.090 |
Why?
|
| Transduction, Genetic | 1 | 2013 | 238 | 0.090 |
Why?
|
| Cell Survival | 1 | 2013 | 576 | 0.090 |
Why?
|
| Histones | 1 | 2014 | 481 | 0.090 |
Why?
|
| HEK293 Cells | 1 | 2013 | 622 | 0.090 |
Why?
|
| Microscopy, Electron | 2 | 2015 | 251 | 0.090 |
Why?
|
| RNA Interference | 1 | 2014 | 618 | 0.090 |
Why?
|
| Amino Acid Sequence | 5 | 2013 | 1590 | 0.080 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2010 | 33 | 0.080 |
Why?
|
| Epitope Mapping | 1 | 2010 | 50 | 0.080 |
Why?
|
| Models, Biological | 3 | 2010 | 1182 | 0.080 |
Why?
|
| Esterases | 1 | 2010 | 13 | 0.080 |
Why?
|
| Aryldialkylphosphatase | 1 | 2010 | 19 | 0.080 |
Why?
|
| Antibodies, Monoclonal | 1 | 2014 | 863 | 0.080 |
Why?
|
| Catalytic Domain | 1 | 2010 | 198 | 0.080 |
Why?
|
| Substrate Specificity | 1 | 2010 | 339 | 0.080 |
Why?
|
| DNA Helicases | 1 | 2011 | 190 | 0.080 |
Why?
|
| Trans-Activators | 1 | 2011 | 311 | 0.080 |
Why?
|
| Stereoisomerism | 2 | 2015 | 69 | 0.080 |
Why?
|
| Breast Neoplasms | 1 | 2018 | 1204 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2009 | 24 | 0.080 |
Why?
|
| Hydrogen Bonding | 1 | 2009 | 129 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 3 | 2021 | 3402 | 0.070 |
Why?
|
| Insulin | 1 | 2013 | 686 | 0.070 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 374 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2018 | 2184 | 0.070 |
Why?
|
| Genome-Wide Association Study | 1 | 2010 | 359 | 0.070 |
Why?
|
| Axons | 2 | 2023 | 123 | 0.070 |
Why?
|
| RNA, Small Interfering | 1 | 2014 | 922 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2013 | 622 | 0.070 |
Why?
|
| Zebrafish | 1 | 2010 | 347 | 0.070 |
Why?
|
| Peptidylprolyl Isomerase | 1 | 2007 | 20 | 0.070 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2011 | 445 | 0.060 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2011 | 565 | 0.060 |
Why?
|
| Catalysis | 2 | 2007 | 162 | 0.060 |
Why?
|
| Dopamine | 1 | 2006 | 107 | 0.060 |
Why?
|
| Aged | 3 | 2018 | 14457 | 0.050 |
Why?
|
| Cerebral Cortex | 2 | 2015 | 263 | 0.050 |
Why?
|
| Biological Assay | 1 | 2022 | 58 | 0.050 |
Why?
|
| Polyphosphates | 1 | 2022 | 12 | 0.050 |
Why?
|
| Culture Media, Conditioned | 1 | 2022 | 51 | 0.050 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2014 | 264 | 0.050 |
Why?
|
| Reflex | 1 | 2021 | 27 | 0.050 |
Why?
|
| DNA-Binding Proteins | 2 | 2023 | 1185 | 0.050 |
Why?
|
| Virulence | 1 | 2002 | 193 | 0.040 |
Why?
|
| Models, Chemical | 1 | 2002 | 139 | 0.040 |
Why?
|
| Head Injuries, Closed | 1 | 2021 | 15 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2002 | 294 | 0.040 |
Why?
|
| Cations, Monovalent | 1 | 2000 | 1 | 0.040 |
Why?
|
| IMP Dehydrogenase | 1 | 2000 | 9 | 0.040 |
Why?
|
| DNA Mutational Analysis | 2 | 2011 | 197 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2015 | 2166 | 0.040 |
Why?
|
| Tunicamycin | 1 | 2018 | 8 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2023 | 2113 | 0.040 |
Why?
|
| Protein Aggregation, Pathological | 1 | 2018 | 19 | 0.040 |
Why?
|
| Proteostasis | 1 | 2018 | 11 | 0.040 |
Why?
|
| Transfection | 1 | 2020 | 695 | 0.040 |
Why?
|
| Time Factors | 1 | 2006 | 3710 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2011 | 490 | 0.040 |
Why?
|
| Gene Editing | 1 | 2022 | 322 | 0.040 |
Why?
|
| RNA | 2 | 2014 | 426 | 0.040 |
Why?
|
| Tryptophan | 1 | 2018 | 57 | 0.040 |
Why?
|
| Peptides | 1 | 2002 | 574 | 0.040 |
Why?
|
| Meglumine | 1 | 2018 | 20 | 0.040 |
Why?
|
| Molecular Sequence Data | 2 | 2012 | 1993 | 0.040 |
Why?
|
| Organometallic Compounds | 1 | 2018 | 66 | 0.030 |
Why?
|
| Unfolded Protein Response | 1 | 2018 | 56 | 0.030 |
Why?
|
| Gene Expression Regulation | 2 | 2015 | 1617 | 0.030 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2015 | 19 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2002 | 881 | 0.030 |
Why?
|
| Contrast Media | 1 | 2018 | 422 | 0.030 |
Why?
|
| Patient Selection | 1 | 2018 | 486 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2018 | 1151 | 0.030 |
Why?
|
| Disease Progression | 1 | 2019 | 1170 | 0.030 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2015 | 71 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2015 | 373 | 0.030 |
Why?
|
| Disulfides | 1 | 2014 | 64 | 0.030 |
Why?
|
| Genotype | 1 | 2015 | 664 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 2013 | 79 | 0.030 |
Why?
|
| Artifacts | 1 | 2014 | 125 | 0.020 |
Why?
|
| HLA-DRB1 Chains | 1 | 2013 | 16 | 0.020 |
Why?
|
| Cell Movement | 1 | 2015 | 457 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2015 | 424 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2015 | 469 | 0.020 |
Why?
|
| Jews | 1 | 2012 | 9 | 0.020 |
Why?
|
| HLA Antigens | 1 | 2013 | 62 | 0.020 |
Why?
|
| Growth Cones | 1 | 2012 | 14 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2015 | 3033 | 0.020 |
Why?
|
| Aging | 1 | 2018 | 745 | 0.020 |
Why?
|
| Leukocytes | 1 | 2013 | 103 | 0.020 |
Why?
|
| Exome | 1 | 2012 | 77 | 0.020 |
Why?
|
| Pancreas | 1 | 2013 | 154 | 0.020 |
Why?
|
| Pedigree | 1 | 2012 | 193 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2012 | 113 | 0.020 |
Why?
|
| Immune System | 1 | 2013 | 130 | 0.020 |
Why?
|
| Oxygen | 1 | 2013 | 317 | 0.020 |
Why?
|
| Age Factors | 1 | 2015 | 1561 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2013 | 517 | 0.020 |
Why?
|
| Insulin-Secreting Cells | 1 | 2013 | 189 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2013 | 402 | 0.020 |
Why?
|
| Prostatic Neoplasms | 1 | 2015 | 418 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 897 | 0.020 |
Why?
|
| Autoimmunity | 1 | 2013 | 237 | 0.020 |
Why?
|
| TATA-Binding Protein Associated Factors | 1 | 2011 | 18 | 0.020 |
Why?
|
| RNA Helicases | 1 | 2011 | 94 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2012 | 311 | 0.020 |
Why?
|
| Kidney Transplantation | 1 | 2013 | 323 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2015 | 692 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2009 | 114 | 0.020 |
Why?
|
| Thermodynamics | 1 | 2009 | 196 | 0.020 |
Why?
|
| Age of Onset | 1 | 2009 | 174 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2011 | 384 | 0.020 |
Why?
|
| tau Proteins | 1 | 2009 | 201 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 5468 | 0.020 |
Why?
|
| Liver | 1 | 2013 | 860 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2009 | 239 | 0.020 |
Why?
|
| Base Sequence | 1 | 2011 | 1331 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2009 | 385 | 0.020 |
Why?
|
| Family | 1 | 2010 | 242 | 0.020 |
Why?
|
| Exons | 1 | 2009 | 199 | 0.020 |
Why?
|
| Staphylococcus aureus | 1 | 2009 | 176 | 0.020 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2009 | 265 | 0.020 |
Why?
|
| Synapses | 1 | 2009 | 184 | 0.020 |
Why?
|
| Amyloid beta-Peptides | 1 | 2009 | 298 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2009 | 417 | 0.020 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 2007 | 11 | 0.020 |
Why?
|
| NIMA-Interacting Peptidylprolyl Isomerase | 1 | 2007 | 4 | 0.020 |
Why?
|
| Titrimetry | 1 | 2007 | 11 | 0.020 |
Why?
|
| Aldehydes | 1 | 2006 | 16 | 0.020 |
Why?
|
| Molecular Conformation | 1 | 2007 | 133 | 0.020 |
Why?
|
| Lipid Peroxidation | 1 | 2006 | 65 | 0.020 |
Why?
|
| Amyloid | 1 | 2006 | 70 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2018 | 6620 | 0.020 |
Why?
|
| Biopolymers | 1 | 2006 | 71 | 0.010 |
Why?
|
| Atherosclerosis | 1 | 2006 | 153 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2013 | 5630 | 0.010 |
Why?
|
| Inosine Monophosphate | 1 | 2000 | 3 | 0.010 |
Why?
|
| Lithium | 1 | 2000 | 21 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 2000 | 99 | 0.010 |
Why?
|
| Sodium | 1 | 2000 | 61 | 0.010 |
Why?
|
| Inflammation | 1 | 2006 | 1146 | 0.010 |
Why?
|
| Magnesium | 1 | 2000 | 54 | 0.010 |
Why?
|
| Potassium | 1 | 2000 | 100 | 0.010 |
Why?
|
| NAD | 1 | 2000 | 53 | 0.010 |
Why?
|
| Alzheimer Disease | 1 | 2006 | 722 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2000 | 381 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2000 | 866 | 0.010 |
Why?
|
| Binding Sites | 1 | 2000 | 906 | 0.010 |
Why?
|